Anthem sues California hospital over alleged fraud in toxicology program

Health insurance giant Anthem and nine of its state affiliates have filed a lawsuit against Sonoma West Medical Center in Sebastopol, California, alleging its toxicology program is fraudulently billing for tests other labs had been ordered to perform.

According to the Sonoma West Times & News, the medical center’s alleged scheme was the work of a personal injury lawyer from Florida named Aaron Durall. The suit claimed Durall came to the hospital last year with a proposal for a quick and substantial new revenue stream to save it from financial ruin.

“Durall under the guise of a corporate shell, would acquire urine through a network of marketers and physicians from around the country; he would consolidate that urine through a toxicology lab in Florida that he owned; and the hospital would bill insurers for the testing even though other labs had been ordered to perform it,” the suit said. “With that simple but deceptive scheme, the hospital could increase the insurance payments for those services up to 100 fold.”

Anthem first brought up these allegations in a Feb. 9 letter, saying the arrangement has resulted in more than $13.5 million in improper payments to the hospital. Sonoma West rejected the allegations, saying it had done nothing wrong while suspending the receipt of samples from Durall’s Reliance Lab.

The Sonoma West Times & News reported that suspension was lifted in May but will now been reinstated with the suit being filed.

Read more at the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”